7 JULY 2005

NEW ZEALAND GAZETTE, No. 105

2487

Product:

PEG-Intron Redipen Injector
Active Ingredient:
Peginterferon alfa-2b 100µg
Dosage Form:
Dual cartridge Redipen
New Zealand Sponsor:
Schering-Plough Animal Health Limited
Manufacturers:
Schering-Plough Limited, (Biotechnology Plant), Singapore, Singapore
Vetter Pharma-Fertigung GmbH & Co Kg, Langenargen, Germany

Product:

PEG-Intron Redipen Injector
Active Ingredient:
Peginterferon alfa-2b 120µg
Dosage Form:
Dual cartridge Redipen
New Zealand Sponsor:
Schering-Plough Animal Health Limited
Manufacturers:
Schering-Plough Limited, (Biotechnology Plant), Singapore, Singapore
Vetter Pharma-Fertigung GmbH & Co Kg, Langenargen, Germany

Product:

PEG-Intron Redipen Injector
Active Ingredient:
Peginterferon alfa-2b 150µg
Dosage Form:
Dual cartridge Redipen
New Zealand Sponsor:
Schering-Plough Animal Health Limited
Manufacturers:
Schering-Plough Limited, (Biotechnology Plant), Singapore, Singapore
Vetter Pharma-Fertigung GmbH & Co Kg, Langenargen, Germany

Product:

PEG-Intron Redipen Injector
Active Ingredient:
Peginterferon alfa-2b 50µg
Dosage Form:
Dual cartridge Redipen
New Zealand Sponsor:
Schering-Plough Animal Health Limited
Manufacturers:
Schering-Plough Limited, (Biotechnology Plant), Singapore, Singapore
Vetter Pharma-Fertigung GmbH & Co Kg, Langenargen, Germany

Product:

PEG-Intron Redipen Injector
Active Ingredient:
Peginterferon alfa-2b 80µg
Dosage Form:
Dual cartridge Redipen
New Zealand Sponsor:
Schering-Plough Animal Health Limited
Manufacturers:
Schering-Plough Limited, (Biotechnology Plant), Singapore, Singapore
Vetter Pharma-Fertigung GmbH & Co Kg, Langenargen, Germany

Product:

Vinorelbine Injection Concentrate
Active Ingredient:
Vinorelbine tartrate 13.85mg equivalent to 10mg vinorelbine
Dosage Form:
Concentrate for injection
New Zealand Sponsor:
Mayne Pharma Pty Limited
Manufacturer:
Mayne Pharma Pty Limited, Mulgrave North, Victoria, Australia

Dated this 1st day of July 2005.

MARK JACOBS, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go4257

Misuse of Drugs Act 1975

Revocation of Authorisation of Medical Practitioners to Prescribe, Administer or Supply Controlled Drugs for the Purpose of Treating People With Drug Dependence

Pursuant to section 24 (8) of the Misuse of Drugs Act 1975, I, David George Chaplow, acting under delegated authority from the Minister of Health, revoke the notice signed by the Director of Mental Health on the 5th day of September 1998 and published in the New Zealand Gazette, 10 September 1998, page 3411, thereby revoking the authority of

Dr Richard McGrath, of Wairarapa
Dr Tim McKenzie, of Wairarapa

to prescribe, administer or supply controlled drugs for the purposes of that section.

Dated at Wellington this 30th day of June 2005.

DR DAVID CHAPLOW, Director of Mental Health.

go4295

New Zealand Public Health and Disability Act 2000

Appointments to the Multi-region Ethics Committee and the Regional Ethics Committees

Pursuant to section 11 (1) of the New Zealand Public Health and Disability Act 2000, I appoint

Georgina Johnson
Simon Jones

to the Multi-region Ethics Committee for three-year terms of office commencing from the date in this notification; and

Joanna Stewart
Sylvester Wayne Miles

to the Northern X Regional Ethics Committee for three-year terms of office commencing from the date in this notification; and

John Fitzgerald

to the Northern Y Regional Ethics Committee for a three-year term of office commencing from the date in this notification; and

Jacqueline Renouf